Ramoplanin
is a atypical glycolipodepsipeptide antibacterial beneath development for the
analysis of CDAD.
Ramoplanin
represents a new chic of antibiotics with a atypical apparatus of activity that
is awful able adjoin Staphylococci.
Ramoplanin
is the aboriginal in a new chic of antimicrobials to ability analytic trials.
It is a glycolipodepsipeptide produced by the beverage of Actinoplanes spp..
Ramoplanin blocks bacterial corpuscle bank biosynthesis by interfering with
peptidoglycan production. Ramoplanin inhibits the
N-acetylglucosaminyltransferase-catalysed about-face of lipid average I to
lipid average II, a footfall that occurs afore the transglycosylation and
transpeptidation reactions. Ramoplanin’s apparatus of activity is audible from
that of glycopeptides. Unlike glycopeptides, ramoplanin does not circuitous
with the D-Ala–D-Ala arrangement of corpuscle bank precursors.
No comments:
Post a Comment